Seres Therapeutics (MCRB) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.57
-0.2
0.18
0.55

Details

Expected EPS
0.55
Actual EPS
0.36
Surprise EPS
-0.19
Surprise Percent
+34.55%

Description

Seres Therapeutics (MCRB) has reported earnings of 0.36 per share for Q2 2023.

0 Comments

Share your thoughts